Buyback and cancellation of Deferred Shares

IXICO announces that it has repurchased, for nominal value, and cancelled deferred shares of 49 pence each in the share capital of the Company. The deferred shares were issued as part of a share capital restructuring undertaken in conjunction with the acquisition of Optimal Medicine Group and was announced on 18 November 2015.

PRESS RELEASE
By |2017-10-10T15:14:51+00:0023 December 2016|Financial|